Next Financial Group’s Acceleron Pharma XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3
Closed -$1K 3051
2021
Q3
$1K Hold
3
﹤0.01% 2726
2021
Q2
$0 Hold
3
﹤0.01% 2758
2021
Q1
$0 Hold
3
﹤0.01% 2676
2020
Q4
$0 Hold
3
﹤0.01% 2457
2020
Q3
$0 Buy
+3
New +$299 ﹤0.01% 2232

Next Financial Group's XLRN Position: Q4 2021 in Review

Next Financial Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3 shares — an estimated $1K sold.

Next Financial Group first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $1K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Next Financial Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Next Financial Group sold 3 Acceleron Pharma shares in Q4 2021, an estimated $1K.
  • Next Financial Group first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
  • Next Financial Group's Acceleron Pharma position peaked at $1K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.